✨ Health Practitioner and Medicines Notices
1118 NEW ZEALAND GAZETTE, No. 42 11 MAY 2006
Appointments to the Health Practitioners Disciplinary Tribunal
Pursuant to section 87 (1) (a) of the Health Practitioners Competence Assurance Act 2003, I appoint health practitioners
Robert John Billings
as a dispensing optician member; and
Pamela Brennan
Ruth O’Rourke
as dental therapist members;
all for five-year terms of office commencing from the date of this notification.
Dated at Wellington this 28th day of April 2006.
PETE HODGSON, Minister of Health.
go2949
Medicines Act 1981
Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Exjade
Active Ingredient: Deferasirox 125mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.
Product: Exjade
Active Ingredient: Deferasirox 250mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.
Product: Exjade
Active Ingredient: Deferasirox 500mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.
Product: Faslodex
Active Ingredient: Fulvestrant 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 5th day of May 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3112
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Durogesic 100µg/h
Active Ingredient: Fentanyl 16.8mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Ireland Limited, Cashel, Co. Tipperary, Ireland
Product: Durogesic 25µg/h
Active Ingredient: Fentanyl 4.2mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Ireland Limited, Cashel, Co. Tipperary, Ireland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 42
Gazette.govt.nz —
NZ Gazette 2006, No 42
✨ LLM interpretation of page content
🏥 Appointments to the Health Practitioners Disciplinary Tribunal
🏥 Health & Social Welfare28 April 2006
Health Practitioners Disciplinary Tribunal, Appointments, Dispensing Optician, Dental Therapist
- Robert John Billings, Appointed dispensing optician member
- Pamela Brennan, Appointed dental therapist member
- Ruth O’Rourke, Appointed dental therapist member
- Pete Hodgson, Minister of Health
🏥 Provisional Consent to the Distribution of New Medicines
🏥 Health & Social Welfare5 May 2006
Medicines Act 1981, Provisional Consent, New Medicines, Exjade, Faslodex
- Don Matheson, Deputy Director-General, Public Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare5 May 2006
Medicines Act 1981, Consent, Changed Medicines, Durogesic
- Don Matheson, Deputy Director-General, Public Health